In your pancreas, GIP strongly stimulates insulin secretion when blood glucose is elevated
However, it is important to note that there is inadequate evidence-based data to support many of these purported benefits at present
not recommended for use with DPP-4 inhibitors Common side effects : Gastrointestinal symptoms (nausea, vomiting, diarrhea) that typically diminish with continued use and proper dose titration Referral to endocrinology or obesity medicine specialists is appropriate for complex cases, including patients with multiple failed therapies, significant comorbidities, or those requiring comprehensive weight management programs
Well work with you to ensure your treatment is safe, effective, and tailored to your needs
People with type 1 diabetes should not use GLP-1 medications as their primary treatment, though they may sometimes be used as additional therapy under careful medical supervision
It activates both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
